Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Syndax Pharmaceuticals Inc Transaction History
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group
- $184 Billion
- Q1 2025
A detailed history of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group holds 200,000 shares of SNDX stock, worth $2.71 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$2.71 Million% of portfolio
1.34%Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
235Shares Held
93.4MCall Options Held
1.04MPut Options Held
822K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$116 Million8.82% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$107 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.87MShares$66.1 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.21MShares$57.2 Million5.73% of portfolio
-
State Street Corp Boston, MA3.97MShares$53.9 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $768M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...